# Ranbaxy Laboratories Limited clinical trials: 100 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 100 trials with Ranbaxy Laboratories Limited as lead sponsor, 0 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Ranbaxy Laboratories Limited: 100 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/ranbaxy-laboratories-limited

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 100
- Recruiting or not yet: 0
- Read on: November 19, 2026

## Trials

The 25 newest of 100, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| December 30, 2014 | NCT02327247 | Bioequivalence Study of Felodipine ER Tablets 10 mg Under Fasting Conditions | Ranbaxy Laboratories Limited | Not applicable | Completed | Healthy | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02327247) |
| December 9, 2014 | NCT02312609 | Bioequivalence Study of Minocycline HCl 135 mg ER Tablet Sunder Fed Conditions | Ranbaxy Laboratories Limited | Not applicable | Completed | Healthy | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02312609) |
| December 9, 2014 | NCT02312297 | Bioequivalence Study of Minocycline HCl 135 mg ER Tablet Sunder Fasting Conditions | Ranbaxy Laboratories Limited | Not applicable | Completed | Healthy | 28 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02312297) |
| December 8, 2014 | NCT02311530 | Bioequivalence Study of Felodipine ER Tablets 10 mg Under Fed Conditions | Ranbaxy Laboratories Limited | Not applicable | Completed | Healthy | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02311530) |
| December 3, 2014 | NCT02306902 | Bioequivalence Study of Fenofibrate Capsules, 130 mg Under Fed Conditions | Ranbaxy Laboratories Limited | Not applicable | Completed | Healthy | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02306902) |
| December 3, 2014 | NCT02306889 | Bioequivalence Study of Fenofibrate Capsules, 130 mg Under Fasting Conditions | Ranbaxy Laboratories Limited | Not applicable | Completed | Healthy | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02306889) |
| July 22, 2014 | NCT02197494 | Bioequivalence Study of Valsartan 320mg Tablets Under Fed Conditions | Ranbaxy Laboratories Limited | Not applicable | Completed | Healthy | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02197494) |
| July 22, 2014 | NCT02197442 | Bioequivalence Study of Valsartan 320mg Tablets Under Fasting Conditions | Ranbaxy Laboratories Limited | Not applicable | Completed | Healthy | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02197442) |
| August 1, 2012 | NCT01654718 | Bioequivalence Study of Pantoprazole Sodium 40 mg Delayed Release Tablets Fed Study | Ranbaxy Laboratories Limited | Not applicable | Completed | Healthy | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01654718) |
| August 1, 2012 | NCT01654705 | Bioequivalence Study of Pantoprazole Sodium 40 mg Delayed Release Tablets Fasting Study | Ranbaxy Laboratories Limited | Not applicable | Completed | Healthy | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01654705) |
| February 1, 2012 | NCT01523119 | Bioequivalence Study of Ondansetron Orally Disintegrating Tablets 8mg Under Fed Conditions | Ranbaxy Laboratories Limited | Not applicable | Completed | Healthy | 35 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01523119) |
| February 1, 2012 | NCT01523093 | Bioequivalence Study of Ondansetron Orally Disintegrating Tablets 8mg Under Fasting Conditions | Ranbaxy Laboratories Limited | Not applicable | Completed | Healthy | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01523093) |
| February 1, 2012 | NCT01523080 | A Relative Bioavailability Study of Acetaminophen Extended Release Gel Tabs 650 mg Under Fasting Condition | Ranbaxy Laboratories Limited | Not applicable | Completed | Healthy | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01523080) |
| January 20, 2012 | NCT01513668 | A Relative Bioavailability Study of Acetaminophen Extended Release Gel Tabs 650 mg Under Fed Condition | Ranbaxy Laboratories Limited | Not applicable | Completed | Healthy | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01513668) |
| December 26, 2011 | NCT01499771 | A Bioequivalence Study Of 80 Mg Atorvastatin Calcium Tablets Versus 80 Mg Lipitor® Tablets Under Fed Conditions | Ranbaxy Laboratories Limited | Phase 1 | Completed | Healthy | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01499771) |
| December 26, 2011 | NCT01499758 | A Bioequivalence Study Of 80 Mg Atorvastatin Calcium Tablets Versus 80 Mg Lipitor® Tablets Under Fasting Conditions. | Ranbaxy Laboratories Limited | Phase 1 | Completed | Healthy | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01499758) |
| January 13, 2011 | NCT01276080 | Bioequivalence Study of Donepezil Hydrochloride 10 mg Tablets Under Fed Conditions | Ranbaxy Laboratories Limited | Phase 1 | Completed | Healthy | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01276080) |
| January 13, 2011 | NCT01276067 | Bioequivalence Study of Donepezil Hydrochloride 10 mg Tablets Under Fasting Conditions | Ranbaxy Laboratories Limited | Phase 1 | Completed | Healthy | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01276067) |
| October 18, 2010 | NCT01222975 | Bioequivalence Study of Risperidone 1 mg Orally-disintegrating Tablets Under Fasting Conditions | Ranbaxy Laboratories Limited | Not applicable | Completed | Healthy | 44 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01222975) |
| October 18, 2010 | NCT01222923 | Bioequivalence Study of Risperidone 1 mg Orally-disintegrating Tablets Under Fed Conditions | Ranbaxy Laboratories Limited | Not applicable | Completed | Healthy | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01222923) |
| October 18, 2010 | NCT01222910 | A Relative Bioavailability Study of Valacyclovir Hydrochloride Tablets 1gm Under Fasting Condition | Ranbaxy Laboratories Limited | Not applicable | Completed | Healthy | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01222910) |
| October 18, 2010 | NCT01222897 | A Relative Bioavailability Study of Valacyclovir Hydrochloride Tablets 1gm Under Fed Condition | Ranbaxy Laboratories Limited | Not applicable | Completed | Healthy | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01222897) |
| March 2, 2010 | NCT01079078 | A Relative Bioavailability Study of Acetaminophen 650 mg Extended Release Gelcaps Under Fed Condition | Ranbaxy Laboratories Limited | Not applicable | Completed | Healthy | 26 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01079078) |
| March 2, 2010 | NCT01079065 | A Relative Bioavailability Study of 20 mg Famotidine Tablets Under Fasting Condition | Ranbaxy Laboratories Limited | Not applicable | Completed | Healthy | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01079065) |
| March 2, 2010 | NCT01079052 | A Relative Bioavailability Study of 20 mg Famotidine Tablets Under Fed Condition | Ranbaxy Laboratories Limited | Not applicable | Completed | Healthy | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01079052) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 5 |
| Not applicable | 95 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 100 |

## Conditions

| Condition group | Trials |
| --- | --- |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Laboratories in the United States](https://specstream.ai/data/businesses/laboratories/united-states)
- [Nursing schools in the United States](https://specstream.ai/data/businesses/nursing-schools/united-states)
- [Clinical laboratories in the United States](https://specstream.ai/data/businesses/clinical-laboratories/united-states)
- [Research institutes in the United States](https://specstream.ai/data/businesses/research-institutes/united-states)
- [Falafel restaurants in the United States](https://specstream.ai/data/businesses/falafel-restaurants/united-states)
- [Turkish restaurants in the United States](https://specstream.ai/data/businesses/turkish-restaurants/united-states)
